The Smallest Heart Pump Is Changing Lives in Big Ways

More than 300,000 patients have been supported with Impella® heart pumps

How Impella® Works

During a minimally invasive Impella heart pump-supported procedure, Impella takes over the pumping function of the heart, ensuring blood flow to critical organs. This allows the interventional cardiologist to perform procedures on patients considered high risk, including surgical turn down patients.

Connect with a Therapy Awareness Manager

Your high-risk or surgical turn down patients with heart failure and coronary artery disease may have treatment options beyond medications and lifestyle changes. Impella could help.

Download the Checklist

Heart Recovery and Higher Life Quality Is Possible

Supports your Heart

Protected PCI with Impella ensures blood flow is maintained to critical organs enabling you to perform a complete and optimized procedure, decreasing the likelihood of repeat procedures and multiple hospital stays.

Improved Quality of Life

In a randomized controlled trial, 8-in-10 patients treated with Impella heart pumps experienced reduction in heart failure symptoms or improvement in heart function.

An Impella Supported Procedure Can Lead To Better Patient Outcomes

Fewer Days in the Hospital

After the procedure compared to traditional therapy such as the intra-aortic balloon pump.

Few Post-Hospital Adverse Events

In 90 days after the procedure, including a reduction in death, heart attack, and stroke compared to other support methods.

Support is nearby

Impella therapy awareness managers (TAMs) provide education on CAD and heart failure, and can help you find a treatment for your patient. Your TAM can help you decide if Impella could benefit your patients who have complex heart conditions and connect you with an Interventional Cardiologist who performs PCI with Impella.

Connect with a TAM

References

Dangas, G.D., et al. (2014). Am J Cardiol, 113(2), 222-228.
Maini, B., et al. (20140. Catheter Cardiovasc Interv, 83(6), E183-E192.
Gregory, D., et al. (2013). J Manag Care Med, 16(1), 61-69.
Gregory, D., et al. (2013). Am Health Drug Benefits, 6(2), 88-99.
O'Neill, W.W., et al. (2012). Circulation, 126(14), 1717-1727.
O'Neill, W.W., et al. (2014). J Interviev Cardiol, 27(1), 1-11.
Roos, J.B., et al. (2013). J Med Econ, 16(3), 3381-390.
PROTECT II Data on File

IMP-5068